Clinical Trial Update: Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of LUMIGAN RC versus DuoTrav in patients needing further intraocular pressure reduction; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))
• LUMIGAN RC (bimatoprost/timolol)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2014-08-15